Various Pathogenic Pseudomonas Strains that Cause Brown Blotch Disease in Cultivated Mushrooms |
Mu, Lin-Lin
(Department of Environmental and Biological Chemistry, Chungbuk National University)
Yun, Yeong-Bae (Department of Environmental and Biological Chemistry, Chungbuk National University) Park, Soo-Jin (Department of Environmental and Biological Chemistry, Chungbuk National University) Cha, Jae-Soon (Department of Plant Medicine, Chungbuk National University) Kim, Young-Kee (Department of Environmental and Biological Chemistry, Chungbuk National University) |
1 | Liu F, Ooi VE, and Chang ST (1997) Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci 60, 763-6. DOI |
2 | Moquet F, Mamoun M, and Olivier JM (1996) Pseudomonas tolaasii and tolaasin: comparison of symptom induction on a wide range of Agaricus bisporus strains. FEMS Microbiol Lett 142, 99-103. DOI |
3 | Munsch P, Alatossava T, Marttinen N, Meyer JM, Christen R, and Gardan L (2002) Pseudomonas costantinii sp. nov., another causal agent of brown blotch disease, isolated from cultivated mushroom sporophores in Finland. Int J Syst Evol Microbiol 52, 1973-83. |
4 | Munoz R, Guieysse B, and Mattiasson B (2003) Phenanthrene biodegradation by an algal-bacterial consortium in two-phase partitioning bioreactors. Appl Microbiol Biotechnol 61, 261-7. DOI |
5 | MushWorld (2004) In Oyster Mushroom Cultivation, Mushroom Grower's Handbook 1, Muchworld, Korea. |
6 | Nie ZJ, Hang BJ, Cai S, Xie XT, He J, and Li SP (2011) Degradation of cyhalofop-butyl (CyB) by Pseudomonas azotoformans strain QDZ-1 and cloning of a novel gene encoding CyB-hydrolyzing esterase. J Agric Food Chem 59, 6040-6. DOI |
7 | Nutkins JC, Mortishire-Smith RJ, Packman LC, Brodey CL, Rainey PB, Johnstone K et al. (1991) Structure determination of tolaasin, an extracellular lipodepsipeptide produced by mushroom pathogen, Pseudomonas tolaasii paine. J Am Chem Soc 113, 2621-7. DOI |
8 | Patel S and Goyal A (2012) Recent development in mushrooms as anti-cancer therapeutics: a review. 3 Biotech 2, 1-15. |
9 | Rainey PB, Brodey CL, and Johnstone K (1991) Biological properties and spectrum of activity of tolaasin, a lipodepsipeptide toxin produced by the mushroom pathogen Pseudomonas tolaasii. Physiol Mol Plant Pathol 39, 57-70. DOI |
10 | Annette FM, Zhontang Y, and William WM (2001) Population dynamics and metabolic activity of Pseudomonas abietaniphila BKME-9 within pulp mill wastewater microbial communities assayed by competitive PCR and RT-PCR. FEMS Microbiol Ecol 38, 21-31. DOI |
11 | Annual Report for Production of Mushroom (2010) Agricultural information and statistics. Ministry of Agricultural and Forestry, Korea. |
12 | Tolaas AG (1915) A bacterial disease of cultivated mushrooms. Phytopathology 5, 51-4. |
13 | Shirata A, Sugaya K, Takasugi M, and Monde K (1995) Isolation and biological activity of toxins produced by a japanese strain of Pseudomonas tolaasii, the pathogen of bacterial rot of cultivated oyster mushroom. Ann Phytopathol Soc Japan 61, 493-502. DOI |
14 | Tamura K, Peterson D, Peterson N, Stecher G, Nei M, and Kumar S (2013) MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30, 2725-9. DOI |
15 | Tikilili PV and Chirwa EMN (2009) Microbial degradation of recalcitrant organics from radioactive waste using indigenous cultures of naphthalene degrading bacteria. Chem Eng Trans 18, 845-50. |
16 | Tsuneda A, Suyama K, Murakami S, and Ohira I (1995) Occurrence of Pseudomonas tolaasii on fruiting bodies of Lentinula edodes formed on Quercus logs. Mycoscience 36, 283-8. DOI |
17 | Wong WC and Preece TF (1979) Identification of Pseudomonas tolaasii: the white line in agar and mushroom tissue block rapid pitting tests. J Appl Bacteriol 47, 401-7. DOI |
18 | Yun YB, Park SW, Cha JS, and Kim YK (2013) Biological characterization of various strains of Pseudomonas tolaasii that causes brown blotch disease. J Korean Soc Appl Biol Chem 56, 415. |
19 | Bernheimer AW and Rudy B (1986) Interactions between membranes and cytolytic peptides. Biochem Biophys Acta 864, 123-41. |
20 | Bassarello C, Lazzaroni S, Bifulco G, Cantore PL, Iacobellis NS, Riccio R et al. (2004) Tolaasins A-E, five new lipodepsipeptides produced by Pseudomonas tolaasii. J Nat Prod 67, 811-6. DOI |
21 | Brodey CL, Rainey PB, Tester M, and Johnstone K (1991) Bacterial blotch disease of the cultivated mushroom is caused by an ion channel forming lipodepsipeptide toxin. Mol Plant-Microbe Interact 4, 407-11. DOI |
22 | Cho KH and Kim YK (2003) Two types of ion channel formation of tolaasin, a Pseudomonas peptide toxin. FEMS Microbiol Lett 221, 221-6. DOI |
23 | Cho KH, Kim ST, and Kim YK (2007) Purification of a pore-forming peptide toxin, tolaasin, produced by Pseudomonas tolaasii 6264. J Biochem Mol Biol 40, 113-8. DOI |
24 | Cho KH, Wang HS, and Kim YK (2010) Temperature-dependent hemolytic activity of membrane pore-forming peptide toxin, tolaasin. J Pept Sci 16, 85-90. DOI |
25 | Coraiola M, Lo Cantore P, Lazzaroni S, Evidente A, Iacobellis NS, and Dalla Serra M (2006) WLIP and tolaasin I, lipodepsipeptides from Pseudomonas reactans and Pseudomonas tolaasii, permeabilise model membranes. Biochem Biophys Acta 1758, 1713-22. DOI |
26 | Fletcher JT (1979) Bacteria and mushrooms. Mushroom J 82, 451-7. |
27 | Gandy DG (1968) A technique for screening bacteria causing brown blotch of cultivated mushrooms. Annual Report of the Glasshouse Crops Research Institute for 1967, 150-4. |
28 | Kubo K and Nanba H (1996) The effect of mushrooms on liver and serum lipids. Altern Ther Health Med 2, 62-9. |
![]() |